The Colorado Infectious Diseases Clinical Trials Unit (IDCTU) conducts a wide range of clinical trials which include HIV/AIDS, COVID-19, MPOX, bacterial and fungal infections.
The IDCTU supports the AIDS Clinical Trial Group (ACTG) in improving the management of HIV and its comorbidities, developing a cure for HIV; and innovating treatments for hepatitis B and emerging infectious diseases.
The IDCTU is one of 76 Clinical Research Sites that comprise the ACTG. ACTG trials are funded by the National Institute of Allergy and Infectious Diseases (NAIDS).
The IDCTU is located at the University of Colorado Anschutz Medical Campus. Visit our Current & Upcoming Studiespage to explore our trials and become a valued participant in our groundbreaking clinical research.